Gene-environment interplay in schizopsychotic disorders
- PMID: 15184100
- DOI: 10.1007/BF03033291
Gene-environment interplay in schizopsychotic disorders
Abstract
Genetic studies have sought to identify subtypes or endophenotypes of schizophrenia in an effort to improve the reliability of findings. A number of chromosomal regions or genes have now been shown to have had replicated linkage to schizophrenia susceptibility. Molecules involved in neurodevelopment or neurotransmitter function are coded by many of the genes that have been implicated in schizophrenia. Studies of neurotransmitter function have identified, among others, a possible role for GABA, glutamate and dopamine in animal models of schizophrenia. GABA neurons that co-express the calcium binding protein parvalbumin have been implicated as have glutamatergic metabotropic receptors and dopamine D3 receptors. Stress influences glutamate and dopamine providing another environmental factor that may interact with the influence of genes on neurotransmitter function. Neurotransmitter interactions include influences on signaling molecules and these too have been implicated in forms of learning thought to be affected in schizophrenia. Results continue to unravel the interplay of genes and environment in the etiology of schizophrenia and other psychotic disorders.
Copyright 2004 FP Graham Publishing Co.
Similar articles
-
[In search of susceptibility genes for schizophrenia].Wien Klin Wochenschr. 2004 Dec 30;116(24):827-33. doi: 10.1007/s00508-004-0256-0. Wien Klin Wochenschr. 2004. PMID: 15690966 Review. German.
-
Schizophrenia as a disorder of neuroplasticity.Int Rev Neurobiol. 2004;59:19-45. doi: 10.1016/S0074-7742(04)59002-5. Int Rev Neurobiol. 2004. PMID: 15006483 Review.
-
Dopamine and glutamate dysfunctions in schizophrenia: role of the dopamine D3 receptor.Neurotox Res. 2004;6(1):63-71. doi: 10.1007/BF03033298. Neurotox Res. 2004. PMID: 15184107 Review.
-
Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.Int Rev Neurobiol. 2007;78:377-95. doi: 10.1016/S0074-7742(06)78012-6. Int Rev Neurobiol. 2007. PMID: 17349867 Review.
-
Glutamatergic control over brain dopamine release in vivo and in vitro.Neurosci Biobehav Rev. 1997 Jul;21(4):481-8. doi: 10.1016/s0149-7634(96)00034-6. Neurosci Biobehav Rev. 1997. PMID: 9195606 Review.
Cited by
-
Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.Neurotox Res. 2008 Oct;14(2-3):79-96. doi: 10.1007/BF03033800. Neurotox Res. 2008. PMID: 19073416 Review.
-
Affective status in relation to impulsive, motor and motivational symptoms: personality, development and physical exercise.Neurotox Res. 2008 Oct;14(2-3):151-68. doi: 10.1007/BF03033807. Neurotox Res. 2008. PMID: 19073423
-
Comorbidity of substance abuse with other psychiatric disorders.Neurotox Res. 2007 Jul;12(1):17-27. doi: 10.1007/BF03033898. Neurotox Res. 2007. PMID: 17513197 Review.
-
Genetic variation and shared biological susceptibility underlying comorbidity in neuropsychiatry.Neurotox Res. 2007 Jul;12(1):29-42. doi: 10.1007/BF03033899. Neurotox Res. 2007. PMID: 17513198 Review.
-
Neurotoxins and neurotoxicity mechanisms. An overview.Neurotox Res. 2006 Dec;10(3-4):263-87. doi: 10.1007/BF03033362. Neurotox Res. 2006. PMID: 17197375 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical